 |
Taking the Leap to Independent Investigation: Writing Workshop
for Preparing a Career Development Award Proposal
|
Since 2016, the Career Development Award Grant Writing Workshop Series, sponsored by the Clinical and Translational Science Institute, has helped 50 early career faculty and postdoctoral trainees from across five BU schools develop skills to write their career development award (CDA), and propel them as independent investigators with an attentive eye on groups known to be less represented in biomedical research. Read More
|
|
|
|
|
The BU CTSI Voucher Program
Applications are Accepted on a Rolling Basis.
The Voucher Program supports the short-term needs of research investigators that are not otherwise covered by grants. Vouchers are intended to enable preliminary work, generate data for new or ongoing projects, and/or secure fee-based core services for expert consultation services. Learn More
|
|
|
|
|
Notice of Special Interest (NOSI): Evaluation of sex differences on HIV-associated comorbidities in the context of stimulant use
Pharmacokinetics (PK) and Pharmacodynamics (PD) of THC in Cannabis and Cannabis Products (R01 - Clinical Trial Optional)
National Institute on Drug Abuse (NIDA)
|
Detecting Cognitive Impairment, Including Dementia, in Primary Care and Other Everyday Clinical Settings for the General Public and Health Equity, Pragmatic Clinical Trials (U01 Clinical Trial Required)
National Institute of Neurological Disorders and Stroke (NINDS)
|
|
|
|
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed)
National Cancer Institute (NCI)
|
Notice of Special Interest (NOSI): Promoting Pain Research Within the NIAMS Mission Areas
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
|
Limited Competition: Caenorhabditis Intervention Testing Program Data Coordinating Center (U24 Clinical Trial Not Allowed)
National Institute on Aging (NIA)
|
|
|
|
Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed)
National Institute of General Medical Sciences (NIGMS)
|
Innovation Award: COVID-19 and Health Equity (U01) Clinical Trials Optional
U.S. Food and Drug Administration (FDA)
|
An Intergenerational Precision Medicine Research Program for the Study of Factor VIII Immunogenicity in Severe Hemophilia A: Hemophilia A Analytical Cohort Research Program (UG3/UH3 Clinical Trial Not Allowed)
National Heart, Lung, and Blood Institute (NHLBI)
|
|
|
|
|
Nucleate is Accepting Applications!
Apply before Nov.1, 20201
Are you an academic trainee (Post-doc/PhD/MBA/MD/JD) interested in building life science startups? Are you passionate about therapeutics, diagnostics, medtech, or synthetic biology? Learn More
|
|
|
|
|
Low-dose mRNA-1273 COVID-19 Vaccine Generates Durable Memory Enhanced by Cross-Reactive T cells
Reports from both Pfizer/BioNTech and Moderna indicate protective immunity of 91% & 93% over the 6-month period after the 2nd immunization. Read More
|
|
|
|
|
Everything You Need to Know about COVID Booster Shots
BU epidemiologist explains why coronavirus vaccine boosters are necessary, whether they’ll protect against the Delta variant. Read More
|
|
|
|
|
Safety and Immunogenicity of SARS-CoV-2 Variant mRNA Vaccine Boosters in Healthy Adults: an Interim Analysis
The emergence of SARS-CoV-2 variants of concern (VOCs) and variants of interest (VOIs) with decreased susceptibility to neutralization has generated interest in assessments of booster doses and variant-specific vaccines. Read More
|
|
|
|
|
Individualizing Treatment in CRPC Based
on Patient & Disease - Specific Factors
Sep. 27, 2021, 7 - 9 p.m.
This program is directed toward urologists, oncologists, and researchers interested in the treatment of prostate cancer. Nurse practitioners, physician assistants, & health care professionals are also invited to participate. Read More
|
|
|
|
|
Building and Supervising a Research Team
Sep. 29, 2021, 3 - 4:30 p.m.
In this workshop, participants will learn how to recruit and bring onboard diverse team members, strategies to build trust and sustain productive interactions within teams, and approaches to keep projects and team members on task and on time. Read More
|
|
|
|
|
COVID-19 Testing Is Here to Stay: The Intersection Between Vaccination and Testing
Sep. 30, 2021, 2 p.m.
Given the challenge from the delta variant, even among the fully vaccinated, and the reality that maybe 40% of those who are infectious have no symptoms, testing is an important tool for slowing the spread of disease. Read More
|
|
|
|
|
The Funding Acknowledgement |
|
|
|
|
The Funding Acknowledgement guides recipients of BU CTSI services, resources, or funding for projects or research through the grant citation process. All recipients are required to cite our grant number in associated presentations and journal publications.
|
|
|
|
|
|
|
|
|
